MTN-020 A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase 3 Safety and Effectiveness Trial of a Vaginal Matrix Ring Containing Dapivirine for the Prevention of HIV-1 Infection in Women

First Page		Document Content
Date: 2011-09-30 12:59:15 Education Microbicides Sexually transmitted diseases and infections Division of Acquired Immunodeficiency Syndrome AIDS Master of Medicine HIV Medical Research Council Clinical trial Health Medicine HIV/AIDS		MTN-020 A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase 3 Safety and Effectiveness Trial of a Vaginal Matrix Ring Containing Dapivirine for the Prevention of HIV-1 Infection in Women Add to Reading List Source URL: www.mtnstopshiv.org Download Document from Source Website File Size: 1,04 MB Share Document on Facebook

	BIO-INNOVATION Health Innovation Innovation for health includes the development of new drugs, vaccines, DocID: 1p3DX - View Document
	Department of Biomathematics Seminar Series: Frontiers in Systems and Integrative Biology Theoretical Approaches towards HIV Vaccine Designs and Incidence Assessment DocID: 1kYh1 - View Document
	EMBARGOED UNTIL Tuesday, April 29, :15 p.m. PDT MEDIA CONTACTS BELOW DocID: 1aAsg - View Document
	color adslicksindd DocID: 1a1MN - View Document
	PRESS RELEASE Under embargo till July 20, 9 a.m. EST Washington, D.C., July 20, A new initiative, the Collaboration for HIV/AIDS Immunological Therapy (CHAIT), will be announced at the HIV Functional Cure Symposi DocID: 19Ru5 - View Document